A Phase 2 interventional study of ALA and Topical Solution Vehicle in Actinic Keratosis, sponsored by DUSA Pharmaceuticals, Inc.. Completed at 8 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-01-18.
Sponsored by DUSA Pharmaceuticals, Inc. (part of Sun Pharmaceutical Industries Limited) · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 29 studies testing Aminolevulinic Acid in Keratosis, Actinic — 1 open to participants now, 2 under way, none of them phase 3. Aminolevulinic Acid · Keratosis, Actinic.
Among the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic, this one is the 7th largest by enrollment, is one of 2 that started in 2016, is one of 11 in phase 2, and was the 16th registered.
343 studies on the registry are indexed under Keratosis, Actinic; 29 are open to participants now.
Browse Keratosis, Actinic studies →1 of the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic is open now, in 1 country. Recruiting first, the newest first:
Shanghai Dermatology Hospital · Sites in China
Ages 18+
By country, each count listing its studies:
Aminolevulinic Acid: first FDA approval 1999 (LEVULAN), first EMA approval 2007. What it is approved for, and how studies give it, is on its page →
Of the 21 Keratosis, Actinic studies recruiting now, 16 (76%) set no upper age limit and 1 (5%) stops at 75 or younger; none take children under 18; 2 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
29 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 12 · Phase 3 5 · Phase 4 8
First in 1997; this study’s year is marked. 2 started in 2016.
This study's enrollment of 137 is above the median of 60 across 295 interventional studies indexed under Keratosis, Actinic.
Median enrollment 32 across the 29 interventional studies. Of the 24 that completed or were terminated, 15 (63%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 29 have an industry lead sponsor. The 10 most frequent:
This study is registered under DUSA Pharmaceuticals, Inc., one of the names counted as Sun Pharmaceutical Industries Limited. Under that name alone:
DUSA Pharmaceuticals, Inc. is the lead sponsor of 11 studies on the registry; none are open to participants now.
16 studies in Keratosis, Actinic by Sun Pharmaceutical Industries Limited: 3 open now, 3 under way, 2 of them phase 3. Of 12 finished, 8 (67%) have results posted.
Among the 16 studies in Keratosis, Actinic by Sun Pharmaceutical Industries Limited, this one is the 9th largest by enrollment of the 15 interventional ones that give a count, is one of 2 that started in 2016, is one of 7 in phase 2, and was the 12th registered.
Sun Pharmaceutical Industries Limited’s Keratosis, Actinic studies by the year they started, since 2008.
None of the studies under way reaches primary completion within a year.
Among the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic, from their registry updates:
Among Sun Pharmaceutical Industries Limited’s 16 in Keratosis, Actinic:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to determine the viability of microneedle lesion preparation (MN) to enhance treatment benefit when performed prior to ALA PDT to an actinic keratosis (AK) field on the face.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
use of the following topical preparations on the extremity to be treated:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Biopsy and archival tissue
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ALA-PDT, 25 min incubation period, 10 mW/cm2 power density for 16 min 40 second light treatment.
Drug: ALA · Device: IBL 10 mW
Microneedle lesion preparation prior to ALA-PDT, 25 min incubation period, 10 mW/cm2 power density for 16 min 40 second light treatment.
Drug: ALA · Device: IBL 10 mW · Procedure: Microneedle lesion preparation
ALA-PDT, 25 min incubation period, 20 mW/cm2 power density for 8 min 20 second light treatment.
Drug: ALA · Device: IBL 20 mW
Microneedle lesion preparation prior to ALA-PDT, 25 min incubation period, 20 mW/cm2 power density for 8 min 20 second light treatment.
Drug: ALA · Procedure: Microneedle lesion preparation · Device: IBL 20 mW
ALA-PDT, 60 min incubation period, 10 mW/cm2 power density for 16 min 40 second light treatment.
Drug: ALA · Device: IBL 10 mW
Microneedle lesion preparation prior to ALA-PDT, 60 min incubation period, 10 mW/cm2 power density for 16 min 40 second light treatment.
Drug: ALA · Device: IBL 10 mW · Procedure: Microneedle lesion preparation
ALA-PDT, 60 min incubation period, 20 mW/cm2 power density for 8 min 20 second light treatment.
Drug: ALA · Device: IBL 20 mW
Microneedle lesion preparation prior to ALA-PDT, 60 min incubation period, 20 mW/cm2 power density for 8 min 20 second light treatment.
Drug: ALA · Procedure: Microneedle lesion preparation · Device: IBL 20 mW
Vehicle (VEH) PDT, 60 minute incubation period, 10 mW/cm2 power density for 16 min 40 second light treatment.
Drug: Topical Solution Vehicle · Device: IBL 10 mW
Microneedle lesion preparation prior to Vehicle PDT, 60 minute incubation period, 10 mW/cm2 power density for 16 min 40 second light treatment.
Drug: Topical Solution Vehicle · Device: IBL 10 mW · Procedure: Microneedle lesion preparation
20% ALA applied to face prior to light treatment
Also known as: Levulan Kerastick, Aminolevulinic acid
Levulan Kerastick containing vehicle ingredients only. Vehicle solution applied to face prior to light treatment
10 J/cm2 blue light delivered at 10 mW/cm2 for 16 minutes 40 seconds
Also known as: Investigational Blue Light (IBL)
Microneedling of all visible/palpable AK lesions prior to solution application.
10 J/cm2 blue light delivered at 20 mW/cm2 for 8 minutes 20 seconds
Also known as: Investigational Blue Light
Complete Clearance Rate
Number of AK Fields with 0 lesions
Time frame: Week 12
Complete Clearance Rate
Number of AK Fields with 0 Lesions
Time frame: Week 8
Subject Satisfaction Score
Subject satisfaction score 1. = Excellent (very satisfied) 2. = Good (moderately satisfied) 3. = Fair (slightly satisfied) 4. = Poor (not satisfied at all)
Time frame: Week 12
Baseline AKCR
AK clearance rate (AKCR) for only those lesions present at Baseline
Time frame: Baseline and Week 8
Baseline AKCR
AK clearance rate for only those lesions present at Baseline
Time frame: Baseline and Week 12
Percent Change
Percent change in the total AK number as compared with Baseline
Time frame: Baseline and Week 8
Percent Change
Percent change in the total AK number as compared with Baseline
Time frame: Baseline and Week 12
Hyperpigmentation
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
Time frame: Baseline
Hyperpigmentation
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
Time frame: 24-48 hours after PDT #1
Hyperpigmentation
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
Time frame: 2 Weeks after PDT #1
Hyperpigmentation
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
Time frame: 8 Weeks after PDT #1
Hyperpigmentation
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
Time frame: 12 Weeks after PDT #1
Hypopigmentation
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
Time frame: Baseline
Hypopigmentation
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
Time frame: 24-48 hours after PDT #1
Hypopigmentation
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
Time frame: 2 Weeks after PDT #1
Hypopigmentation
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
Time frame: 8 Weeks after PDT #1
Hypopigmentation
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
Time frame: 12 Weeks after PDT #1
Erythema
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
Time frame: Baseline
Erythema
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
Time frame: 5 minutes after PDT #1
Erythema
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
Time frame: 24-48 hours after PDT #1
Erythema
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
Time frame: 2 Weeks after PDT #1
Erythema
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
Time frame: 8 Weeks after PDT #1
Erythema
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
Time frame: 12 Weeks after PDT #1
Edema
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
Time frame: Baseline
Edema
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
Time frame: 5 minutes after PDT #1
Edema
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
Time frame: 24-48 hours after PDT #1
Edema
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
Time frame: 2 weeks after PDT #1
Edema
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
Time frame: 8 Weeks after PDT #1
Edema
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
Time frame: 12 Weeks after PDT #1
Stinging/Burning
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
Time frame: Baseline
Stinging/Burning
Immediately after PDT, the most intensive, acute perception of Stinging/Burning DURING treatment will be recorded. STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
Time frame: During PDT #1
Stinging/Burning
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
Time frame: 5 minutes after PDT #1
Stinging/Burning
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
Time frame: 24-48 Hours after PDT #1
Stinging/Burning
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
Time frame: 2 Weeks after PDT #1
Stinging/Burning
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
Time frame: 8 Weeks after PDT #1
Stinging/Burning
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
Time frame: 12 Weeks after PDT #1
Scaling & Dryness
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
Time frame: Baseline
Scaling & Dryness
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
Time frame: 24-48 hours after PDT #1
Scaling & Dryness
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
Time frame: 2 Weeks after PDT #1
Scaling & Dryness
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
Time frame: 8 Weeks after PDT #1
Scaling & Dryness
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
Time frame: 12 Weeks after PDT #1
Oozing/Vesiculation/Crusting
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
Time frame: Baseline
Oozing/Vesiculation/Crusting
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
Time frame: 24-48 hours after PDT #1
Oozing/Vesiculation/Crusting
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
Time frame: 2 Weeks after PDT #1
Oozing/Vesiculation/Crusting
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
Time frame: 8 Weeks after PDT #1
Oozing/Vesiculation/Crusting
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
Time frame: 12 Weeks after PDT #1
| Milestone | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH 60 Min 10 mW | VEH 60 Min 10 mW |
|---|---|---|---|---|---|---|---|---|---|---|
| Started | 25 | 25 | 27 | 27 | 29 | 29 | 26 | 26 | 30 | 30 |
| Completed | 24 | 24 | 27 | 27 | 28 | 28 | 23 | 23 | 29 | 29 |
| Not completed | 1 | 1 | 0 | 0 | 1 | 1 | 3 | 3 | 1 | 1 |
| Withdrew: Withdrawal by subject | 1 | 1 | 0 | 0 | 1 | 1 | 3 | 3 | 1 | 1 |
Number of AK Fields with 0 lesions
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Complete Clearance Rate | 16 | 15 | 10 | 12 | 19 | 15 | 18 | 18 | 4 | 4 |
Number of AK Fields with 0 Lesions
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Complete Clearance Rate | 5 | 7 | 7 | 7 | 13 | 11 | 8 | 9 | 4 | 2 |
Subject satisfaction score 1. = Excellent (very satisfied) 2. = Good (moderately satisfied) 3. = Fair (slightly satisfied) 4. = Poor (not satisfied at all)
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Excellent (very satisfied) | 15 | 13 | 21 | 21 | 18 | 18 | 15 | 14 | 8 | 8 |
| Good (moderately satisfied) | 8 | 10 | 5 | 5 | 10 | 9 | 7 | 8 | 3 | 3 |
| Fair (slightly satisfied) | 1 | 1 | 1 | 1 | 0 | 1 | 4 | 4 | 7 | 7 |
| Poor (not satisfied) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 12 |
AK clearance rate (AKCR) for only those lesions present at Baseline
| percentage cleared | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline AKCR | 74.5 ± 24.14 | 72.3 ± 30.15 | 75.0 ± 27.03 | 69.6 ± 31.4 | 85.4 ± 22.26 | 83.4 ± 22.63 | 86.1 ± 15.59 | 80.6 ± 22.61 | 40.6 ± 35.66 | 34.4 ± 36.66 |
AK clearance rate for only those lesions present at Baseline
| percentage cleared | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline AKCR | 92.2 ± 16.28 | 89.2 ± 19.96 | 82.3 ± 22.32 | 86.7 ± 16.44 | 93.2 ± 13.04 | 95.1 ± 10.4 | 96.3 ± 7.49 | 94.8 ± 13.34 | 40.9 ± 37.24 | 43.1 ± 40.42 |
Percent change in the total AK number as compared with Baseline
| percent change | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Percent Change | -65.9 ± 28.4 | -68.6 ± 30.99 | -64.7 ± 32.32 | -63.4 ± 36.04 | -72.9 ± 29.58 | -69.6 ± 34.46 | -79.4 ± 17.3 | -74.2 ± 28.56 | -27.9 ± 47.29 | -13.8 ± 49.02 |
Percent change in the total AK number as compared with Baseline
| percent change | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Percent Change | -87.0 ± 22.52 | -87.3 ± 20.45 | -75.0 ± 32.35 | -80.0 ± 25.1 | -88.9 ± 21.36 | -87.4 ± 17.47 | -95.5 ± 10.16 | -92.6 ± 19.08 | -26.0 ± 50.29 | -18.5 ± 54.77 |
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 12 | 12 | 16 | 16 | 16 | 16 | 13 | 13 | 15 | 15 |
| Grade 1 | 10 | 11 | 6 | 6 | 11 | 9 | 8 | 8 | 12 | 13 |
| Grade 2 | 2 | 1 | 5 | 5 | 1 | 3 | 3 | 3 | 1 | 0 |
| Grade 3 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 |
| Grade 4 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 |
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 12 | 12 | 15 | 15 | 14 | 15 | 10 | 10 | 15 | 15 |
| Grade 1 | 11 | 11 | 6 | 7 | 11 | 10 | 11 | 11 | 12 | 13 |
| Grade 2 | 1 | 1 | 6 | 5 | 2 | 2 | 1 | 2 | 1 | 0 |
| Grade 3 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 2 | 1 |
| Grade 4 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 |
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 11 | 11 | 14 | 14 | 16 | 16 | 12 | 12 | 16 | 15 |
| Grade 1 | 12 | 12 | 8 | 8 | 9 | 9 | 8 | 8 | 11 | 13 |
| Grade 2 | 1 | 1 | 5 | 5 | 2 | 2 | 2 | 3 | 2 | 0 |
| Grade 3 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 2 |
| Grade 4 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 11 | 11 | 16 | 16 | 16 | 16 | 10 | 10 | 16 | 16 |
| Grade 1 | 11 | 11 | 6 | 6 | 7 | 8 | 9 | 9 | 10 | 10 |
| Grade 2 | 1 | 1 | 5 | 5 | 3 | 2 | 3 | 3 | 1 | 1 |
| Grade 3 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 |
| Grade 4 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 10 | 10 | 15 | 15 | 19 | 19 | 10 | 10 | 16 | 16 |
| Grade 1 | 12 | 12 | 7 | 7 | 8 | 8 | 10 | 9 | 10 | 11 |
| Grade 2 | 1 | 1 | 5 | 5 | 0 | 0 | 1 | 3 | 2 | 1 |
| Grade 3 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 2 | 2 |
| Grade 4 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 16 | 18 | 20 | 21 | 23 | 24 | 20 | 20 | 25 | 26 |
| Grade 1 | 8 | 6 | 7 | 6 | 5 | 4 | 5 | 5 | 5 | 4 |
| Grade 2 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 01 | 1 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 17 | 18 | 20 | 21 | 22 | 23 | 18 | 18 | 26 | 27 |
| Grade 1 | 7 | 6 | 7 | 6 | 5 | 4 | 5 | 5 | 4 | 3 |
| Grade 2 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 15 | 17 | 21 | 22 | 21 | 23 | 16 | 16 | 25 | 26 |
| Grade 1 | 9 | 7 | 6 | 5 | 7 | 4 | 8 | 8 | 5 | 4 |
| Grade 2 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 15 | 17 | 21 | 21 | 18 | 19 | 15 | 15 | 23 | 23 |
| Grade 1 | 8 | 6 | 6 | 6 | 8 | 7 | 8 | 8 | 6 | 6 |
| Grade 2 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 16 | 18 | 18 | 20 | 21 | 21 | 16 | 16 | 23 | 22 |
| Grade 1 | 7 | 5 | 9 | 7 | 7 | 7 | 7 | 7 | 7 | 8 |
| Grade 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 12 | 12 | 16 | 16 | 17 | 16 | 16 | 15 | 15 | 15 |
| Grade 1 | 10 | 11 | 8 | 8 | 12 | 12 | 9 | 9 | 12 | 11 |
| Grade 2 | 2 | 1 | 3 | 3 | 0 | 1 | 1 | 2 | 3 | 4 |
| Grade 3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 3 | 4 | 3 | 3 | 2 | 2 | 1 | 1 | 12 | 12 |
| Grade 1 | 3 | 5 | 9 | 9 | 2 | 4 | 6 | 8 | 7 | 9 |
| Grade 2 | 15 | 13 | 4 | 7 | 12 | 12 | 9 | 10 | 10 | 8 |
| Grade 3 | 4 | 3 | 11 | 8 | 12 | 10 | 9 | 5 | 1 | 1 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 |
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 11 | 12 |
| Grade 1 | 0 | 0 | 1 | 2 | 2 | 3 | 0 | 2 | 9 | 10 |
| Grade 2 | 11 | 14 | 9 | 14 | 6 | 9 | 10 | 10 | 10 | 8 |
| Grade 3 | 14 | 10 | 13 | 8 | 17 | 12 | 12 | 9 | 0 | 0 |
| Grade 4 | 0 | 0 | 3 | 2 | 3 | 4 | 3 | 4 | 0 | 0 |
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 9 | 10 | 14 | 14 | 15 | 15 | 12 | 13 | 13 | 13 |
| Grade 1 | 13 | 11 | 9 | 10 | 9 | 10 | 11 | 9 | 14 | 14 |
| Grade 2 | 3 | 3 | 4 | 3 | 4 | 3 | 2 | 3 | 3 | 3 |
| Grade 3 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 12 | 12 | 16 | 18 | 18 | 17 | 16 | 15 | 14 | 14 |
| Grade 1 | 10 | 10 | 9 | 7 | 7 | 8 | 7 | 9 | 10 | 10 |
| Grade 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 0 | 5 | 5 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 15 | 14 | 19 | 18 | 20 | 19 | 16 | 17 | 15 | 14 |
| Grade 1 | 7 | 8 | 7 | 8 | 7 | 8 | 8 | 7 | 8 | 9 |
| Grade 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 7 | 7 |
| Grade 3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 25 | 25 | 27 | 27 | 29 | 29 | 26 | 26 | 30 | 30 |
| Grade 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 20 | 20 | 23 | 23 | 23 | 26 | 22 | 24 | 29 | 28 |
| Grade 1 | 3 | 4 | 2 | 3 | 5 | 1 | 2 | 1 | 1 | 2 |
| Grade 2 | 2 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| Grade 3 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 1 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 13 | 18 | 20 | 20 | 17 | 14 | 8 | 13 | 29 | 29 |
| Grade 1 | 8 | 4 | 3 | 3 | 5 | 9 | 9 | 5 | 0 | 1 |
| Grade 2 | 3 | 2 | 3 | 3 | 4 | 3 | 6 | 3 | 1 | 0 |
| Grade 3 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 25 | 24 | 25 | 25 | 28 | 28 | 24 | 25 | 30 | 30 |
| Grade 1 | 0 | 1 | 2 | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| Grade 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 24 | 24 | 27 | 27 | 27 | 27 | 24 | 24 | 29 | 29 |
| Grade 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 24 | 24 | 27 | 27 | 28 | 28 | 24 | 24 | 30 | 30 |
| Grade 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 24 | 24 | 27 | 27 | 29 | 29 | 25 | 25 | 29 | 30 |
| Grade 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| Grade 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Immediately after PDT, the most intensive, acute perception of Stinging/Burning DURING treatment will be recorded. STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 21 | 24 |
| Grade 1 | 9 | 14 | 7 | 16 | 5 | 5 | 5 | 6 | 9 | 6 |
| Grade 2 | 13 | 9 | 16 | 7 | 15 | 17 | 10 | 12 | 0 | 0 |
| Grade 3 | 2 | 0 | 3 | 3 | 9 | 7 | 11 | 8 | 0 | 0 |
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 6 | 9 | 7 | 9 | 5 | 5 | 5 | 7 | 28 | 29 |
| Grade 1 | 16 | 14 | 12 | 13 | 16 | 19 | 9 | 11 | 2 | 1 |
| Grade 2 | 3 | 2 | 8 | 5 | 7 | 4 | 11 | 7 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 9 | 8 | 12 | 13 | 7 | 6 | 8 | 9 | 28 | 28 |
| Grade 1 | 6 | 14 | 8 | 11 | 15 | 16 | 9 | 10 | 2 | 2 |
| Grade 2 | 10 | 3 | 6 | 3 | 6 | 6 | 8 | 6 | 0 | 0 |
| Grade 3 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 24 | 24 | 26 | 26 | 28 | 28 | 25 | 25 | 30 | 30 |
| Grade 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 24 | 24 | 27 | 27 | 27 | 27 | 23 | 22 | 28 | 29 |
| Grade 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 0 |
| Grade 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 24 | 24 | 27 | 26 | 27 | 27 | 24 | 24 | 30 | 30 |
| Grade 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Grade 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 19 | 19 | 18 | 18 | 16 | 16 | 17 | 17 | 19 | 19 |
| Grade 1 | 5 | 5 | 7 | 8 | 12 | 10 | 8 | 7 | 8 | 8 |
| Grade 2 | 1 | 1 | 2 | 0 | 1 | 3 | 1 | 2 | 3 | 3 |
| Grade 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 15 | 15 | 16 | 17 | 16 | 17 | 17 | 16 | 20 | 20 |
| Grade 1 | 7 | 7 | 7 | 7 | 6 | 7 | 3 | 6 | 7 | 8 |
| Grade 2 | 1 | 2 | 3 | 3 | 4 | 2 | 3 | 2 | 2 | 1 |
| Grade 3 | 2 | 1 | 1 | 0 | 1 | 1 | 2 | 1 | 1 | 1 |
| Grade 4 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 16 | 17 | 16 | 16 | 20 | 21 | 20 | 21 | 22 | 23 |
| Grade 1 | 8 | 7 | 10 | 7 | 5 | 4 | 3 | 1 | 8 | 7 |
| Grade 2 | 0 | 0 | 1 | 4 | 3 | 3 | 1 | 2 | 0 | 0 |
| Grade 3 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 19 | 20 | 20 | 21 | 22 | 22 | 18 | 19 | 22 | 22 |
| Grade 1 | 4 | 3 | 6 | 5 | 3 | 3 | 4 | 3 | 4 | 3 |
| Grade 2 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 |
| Grade 3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 23 | 22 | 23 | 22 | 25 | 24 | 20 | 21 | 23 | 23 |
| Grade 1 | 0 | 1 | 4 | 5 | 3 | 3 | 3 | 2 | 6 | 6 |
| Grade 2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
| Grade 3 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 23 | 24 | 24 | 25 | 29 | 29 | 24 | 24 | 29 | 29 |
| Grade 1 | 1 | 0 | 2 | 1 | 0 | 0 | 2 | 2 | 0 | 0 |
| Grade 2 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
| Grade 3 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 18 | 20 | 21 | 23 | 24 | 25 | 20 | 19 | 29 | 29 |
| Grade 1 | 4 | 2 | 3 | 2 | 2 | 1 | 4 | 5 | 0 | 0 |
| Grade 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
| Grade 3 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 23 | 24 | 25 | 26 | 26 | 27 | 24 | 25 | 28 | 28 |
| Grade 1 | 1 | 0 | 2 | 0 | 2 | 1 | 1 | 0 | 1 | 1 |
| Grade 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
| Grade 3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 23 | 23 | 25 | 25 | 25 | 26 | 23 | 23 | 26 | 26 |
| Grade 1 | 0 | 0 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Grade 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 2 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
| AK Fields | MN + ALA 25 Min 10 mW | ALA 25 Min 10 mW | MN + ALA 25 Min 20 mW | ALA 25 Min 20 mW | MN + ALA 60 Min 10mW | ALA 60 Min 10 mW | MN + ALA 60 Min 20 mW | ALA 60 Min 20 mW | MN + VEH | VEH PDT |
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | 24 | 24 | 27 | 27 | 28 | 28 | 23 | 23 | 29 | 29 |
| Grade 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Grade 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Grade 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Collected over 3 months. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| ALA 25 Min 10 mW | 0/25 (0%) | 0/25 (0%) | 1/25 (4%) |
| ALA 25 Min 20 mW | 0/27 (0%) | 0/27 (0%) | 1/27 (3.7%) |
| ALA 60 Min 10 mW | 0/29 (0%) | 0/29 (0%) | 4/29 (13.8%) |
| ALA 60 Min 20 mW | 0/26 (0%) | 1/26 (3.8%) | 7/26 (26.9%) |
| VEH 60 Min 10 mW | 0/30 (0%) | 0/30 (0%) | 2/30 (6.7%) |
| Event | ALA 25 Min 10 mW | ALA 25 Min 20 mW | ALA 60 Min 10 mW | ALA 60 Min 20 mW | VEH 60 Min 10 mW |
|---|---|---|---|---|---|
| unstable anginaCardiac disorders | 0/25 | 0/27 | 0/29 | 1/26 | 0/30 |
| Event | ALA 25 Min 10 mW | ALA 25 Min 20 mW | ALA 60 Min 10 mW | ALA 60 Min 20 mW | VEH 60 Min 10 mW |
|---|---|---|---|---|---|
| PainInjury, poisoning and procedural complications | 1/25 | 1/27 | 3/29 | 7/26 | 0/30 |
| Upper respiratory tract infectionInfections and infestations | 0/25 | 0/27 | 1/29 | 0/26 | 2/30 |
| Age, Continuous(years) | ALA 25 Min 10 mW | ALA 25 Min 20 mW | ALA 60 Min 10 mW | ALA 60 Min 20 mW | VEH 60 Min 10 mW | Total |
|---|---|---|---|---|---|---|
| Mean | 66 ± 10 | 64 ± 8 | 67 ± 8 | 66 ± 9 | 64 ± 10 | 65 ± 9 |
| Sex: Female, Male(Participants) | ALA 25 Min 10 mW | ALA 25 Min 20 mW | ALA 60 Min 10 mW | ALA 60 Min 20 mW | VEH 60 Min 10 mW | Total |
|---|---|---|---|---|---|---|
| Female | 8 | 7 | 5 | 6 | 3 | 29 |
| Male | 17 | 20 | 24 | 20 | 27 | 108 |
| Ethnicity (NIH/OMB)(Participants) | ALA 25 Min 10 mW | ALA 25 Min 20 mW | ALA 60 Min 10 mW | ALA 60 Min 20 mW | VEH 60 Min 10 mW | Total |
|---|---|---|---|---|---|---|
| Hispanic or Latino | 0 | 0 | 1 | 0 | 0 | 1 |
| Not Hispanic or Latino | 25 | 27 | 28 | 26 | 30 | 136 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | ALA 25 Min 10 mW | ALA 25 Min 20 mW | ALA 60 Min 10 mW | ALA 60 Min 20 mW | VEH 60 Min 10 mW | Total |
|---|---|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 | 0 | 0 |
| Black or African American | 0 | 0 | 0 | 0 | 0 | 0 |
| White | 25 | 27 | 29 | 26 | 30 | 137 |
| More than one race | 0 | 0 | 0 | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 | 0 |
| Skin Type(Participants) | ALA 25 Min 10 mW | ALA 25 Min 20 mW | ALA 60 Min 10 mW | ALA 60 Min 20 mW | VEH 60 Min 10 mW | Total |
|---|---|---|---|---|---|---|
| Type I - Burns easily, never tans | 3 | 2 | 2 | 0 | 0 | 7 |
| Type II - Burns easily, tans minimally | 10 | 12 | 19 | 14 | 21 | 76 |
| Type III - Burns moderately, tans gradually | 12 | 11 | 6 | 10 | 9 | 48 |
| Type IV - Burns minimally, tans well | 0 | 2 | 2 | 2 | 0 | 6 |
The record gives a start of Mar 2016, a primary completion of Sep 2016 and a completion of Sep 2016. It does not say whether these dates are actual or estimated.
Results were first posted in Dec 2017, 1 year 3 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Aminolevulinic Acid